November 2003

J Psychiatry Neurosci 2003;28(6)

Review Papers

Molecular genetics of schizophrenia: a critical review
N. Berry, V. Jobanputra, H. Pal

Brain modules of hallucination: an analysis of multiple patients with brain lesions
C.M.J. Braun, M. Dumont,  J. Duval, I. Hamel-Hébert, L. Godbout

Research Paper

Effects of diazepam on facial emotion recognition
N.J. Coupland, A.J. Singh, R.A. Sustrik, P. Ting, R.J. Blair

Brief Report

A new method for rapidly and simultaneously decreasing serotonin and catecholamine synthesis in humans
M. Leyton, V. Kwai Pun,  C. Benkelfat, S.N. Young

CCNP News and Views

The 26th Annual Meeting of the Canadian College of Neuropsychopharmacology

Letter to the Editors

Buspirone for anxiety and agitation in dementia
J.P. Cooper

Psychopharmacology for the Clinician

Are SAMe and 5-HTP safe and effective treatments for depression?
S.N. Young

September 2003

J Psychiatry Neurosci 2003;28(5)

Editorial

Peer review of manuscripts: theory and practice
S.N. Young

Debate

Antidepressants and suicide: risk–benefit conundrums
D. Healy,  C. Whitaker

Suicidality with selective serotonin reuptake inhibitors: Valid claim?
Y.D. Lapierre

Commentary

Anterior cingulate dysfunction: Implications for psychiatric disorders?
M. Yücel, S.J. Wood, A. Fornito, J. Riffkin, D. Velakoulis

Research Papers

Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorder
C. Baethge, P. Gruschka, M.N. Smolka, A. Berghöfer, T. Bschor, B. Müller-Oerlinghausen, M. Bauer

Beclomethasone-induced vasoconstriction in women with major depressive disorder
N.J. Coupland, K.M. Hegadoren, J. Myrholm

CCNP News and Views

Canadian College of Neuropsychopharmacology 2003 Award Winners

Book Reviews

Handbook of Transcranial Magnetic Stimulation.
Z. Nahas

Foundations in Social Neuroscience.
S.N. Young, D.S. Moskowitz

Psychiatry in the Elderly.
J.S. Lok, J.K. Le Clair

Psychiatry in Canada: Fifty Years.
R.T. Joffe

Psychopharmacology for the Clinician

A 56-year-old woman with recurrent major depressive disorder refractory to medication had a good response to an acute course of right unilateral electroconvulsive therapy (ECT) but experienced significant cognitive effects and refused maintenance ECT. Is she a good candidate for repetitive transcranial magnetic stimulation?
R.G. Cooke

July 2003

J Psychiatry Neurosci 2003;28(4)

Editorial

Neurotransmitter interactions in psychotropic drug action: beyond dopamine and serotonin
A. J. Greenshaw

Review Paper

A review of olanzapine-associated toxicity and fatality in overdose
P. Chue,  P. Singer

The role of GABAA receptors in mediating the effects of alcohol in the central nervous system
M. Davies

Understanding antipsychotic “atypicality”: a clinical and pharmacological moving target
G. Remington

Research Papers

Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia
E. Suzuki, T. Nakaki, M. Nakamura, H. Miyaoka

Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects
M. Kiang, Z.J. Daskalakis, B.K. Christensen, G. Remington, S. Kapur

Book Reviews

The Psychopharmacology of Herbal Medicine: Plant Drugs That Alter Mind, Brain and Behavior
R.T. Coutts

Psychopharmacology for the Clinician

What is a recommended treatment for aggression in a patient with schizophrenia?
G. Gobbi, G. Debonnel

May 2003

J Psychiatry Neurosci 2003;28(3)

Editorial

Brand versus generic medications: the money, the patient and the research
P. Blier

Review Paper

Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models
S. Rotzinger, F. J. Vaccarino

Research Papers

Smoking and tardive dyskinesia: lack of involvement of the CYP1A2 gene
S. Chong, E. Tan, C.H. Tan, Mythily

Treatment of primary insomnia with melatonin: a double-blind, placebo-controlled, crossover study
L.G. Almeida Montes, M.P. Ontiveros Uribe, J.Cortés Sotres, G. Heinze Martin

Spontaneously hypertensive rats: further evaluation of age-related memory performance and cholinergic marker expression
C.M. Hernandez, H. Høifødt, A.V. Terry Jr.

Brief Report

Hypothalamic-pituitary-thyroid system activity during lithium augmentation therapy in patients with unipolar major depression
T. Bschor, C. Baethge, M. Adli, U. Lewitzka, U. Eichmann, M. Bauer

Letters to the Editors

Left with the voices or hearing right? Lateralization of auditory verbal hallucinations in schizophrenia
I.E.C. Sommer, A. Aleman, R.S. Kahn

Left with the voices or hearing right? Lateralization of auditory verbal hallucinations in schizophrenia; The authors respond.
E. Stip, L.A. Bentaleb

Psychopharmacology for the Clinician

Tardive dystonia and its treatment
S. Sethi

Diagnostic considerations
P.I. Rosebush, M.F. Mazurek

March 2003

J Psychiatry Neurosci 2003;28(2)

Editorial

Lifestyle drugs, mood, behaviour and cognition
S.N. Young

Commentary

The prodromal stage of psychotic illness: Observation, detection or intervention
J. Addington

Review Paper

Interactions between the cytochrome P450 system and the second-generation antipsychotic
T.I. Prior, G.B.Baker

Research Papers

Effects of dextroamphetamine, lithium chloride, sodium valproate and carbamazepine on intraplatelet Ca2+ levels
M.L. Ulrich, S. Rotzinger,S.J. Asghar, P. Jurasz, V.A. Tanay,S.M.J. Dunn, M. Radomski, A. Greenshaw, P.H. Silverstone

Pentagastrin-induced release of free fatty acids in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol
J.D. Morrow, K. McManus,G.R. Tait, F. Bellavance, W. Chrapko,N. Lara,J.M. Le Mellédo

Letters to the Editors

Thyroid hormone treatment for lithium-induced thyroid dysfunction in mood disorder
R. Ramasubbu

Manic-switch induced by fluvoxamine in abstinent pure methamphetamine abusers
M. Won, et al

CCNP News and Views

The University of Ottawa model for obtaining the needed spectrum of psychiatric services: its relevance in the world today
G.J.Sarwer-Foner

Book Reviews

Mood Disorders in Women
L. Calhoun

Psychiatric Medications for Older Adults: The concise Guide
J. Sadovoy

Psychopharmacology for the Clinician

Is tryptophan a natural hypnotic?
S.N. Young

January 2003

J Psychiatry Neurosci 2003;28(1)

Editorial

Treating mood disorders
R.T. Joffe

Review Papers

Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer’s disease
K.L. Lanctôt, N. Herrmann, M.M. LouLou

Dopamine genes and attention-deficit hyperactivity disorder: a review
S. DiMaio; N. Grizenko; R. Joober

Research Papers

Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia
A.N. Singh, C. Barlas, H. Saeedi, R.K. Mishra

Substance use and cognition in early psychosis
A. Pencer, J. Addington

Brief Report

Mirtazapine for treatment-resistant depression: a preliminary report
D.D.C. Wan, D. Kundhur, K. Solomons, L.N. Yatham, R.W. Lam

Psychopharmacology for the Clinician

What treatment options exist for alcohol abuse?
M. Dongier

Reviewers

Reviewers

January 2004

J Psychiatry Neurosci 2004;29(1)

Editorial

Does lithium save lives?
R.T. Joffe

Review papers

The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-α-induced depression
M.C. Wichers, M. Maes

Eating disorders and the serotonin connection: state, trait and developmental effects
H. Steiger

Research Papers

Immediate effects of risperidone on cerebral activity in healthy subjects: a comparison with subjects with first-episode schizophrenia
C.J. Lane, E.T.C. Ngan, L.N. Yatham, T.J. Ruth, P.F. Liddle

Heroin and cocaine co-use in a group of injection drug users in Montréal
F. Leri, J. Stewart, A. Tremblay, J. Bruneau

The physician-scientist in Canadian psychiatry
W.G. Honer, M.A. Linseman

Brief Report

Olanzapine in the treatment of pervasive developmental disorders: a case series analysis
C. Stavrakaki, R. Antochi, P.C. Emer

CCNP News and Views

The 27th Annual Meeting of the Canadian College of Neuropsychopharmacology Kingston, Ontario, Canada, May 29–June 1, 2004

Reviewers

Reviewers

March 2004

J Psychiatry Neurosci 2004;29(2)

Editorial

What exactly is a mood stabilizer?
L.T. Young

Review papers

Semantics and N400: insights for schizophrenia
N. Kumar, J.B. Debruille

Should cognitive deficit be a diagnostic criterion for schizophrenia?
R. Lewis

Research Papers

Orphanin FQ/nociceptin suppresses motor activity through an action along the mesoaccumbens axis in rats
S. Narayanan, H. Lam, F.I. Carroll, K. Lutfy

Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors
M. Bourin, E. Mocaër, R. Porsolt

Brief Report

Eating disorders with binge-eating behaviour are associated with the s allele of the 3′-UTR VNTR polymorphism of the dopamine transporter gene
M. Shinohara, H. Mizushima, M. Hirano, K. Shioe, M. Nakazawa, Y. Hiejima, Y. Ono, S. Kanba

Cotard’s syndrome with schizophreniform disorder can be successfully treated with electroconvulsive therapy: case report
O. Caliyurt, E. Vardar, C. Tuglu

CCNP News and Views

The 27th Annual Meeting of the Canadian College of Neuropsychopharmacology Kingston, Ontario, Canada, May 29–June 1, 2004

Psychopharmacology for the Clinician

What are the diagnostic criteria, therapy and prophylaxis for discontinuation symptoms due to SSRIs?
T. Higuchi

May 2004

J Psychiatry Neurosci 2004;29(3)

Editorial

Neurobiology of severe mental disorders: from cell to bedside 25th International Symposium of the Centre de recherche en sciences neurologiques, Université de Montréal
P.P. Rompré, E. Stip, L.E. Trudeau

CRSN Symposium: Focus on Depression, Part I

Gene-environment interaction and the genetics of depression
K.P. Lesch

Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression
N. Barden

Implications of adult hippocampal neurogenesis in antidepressant action
J.E. Malberg

Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response
P. Blier, G. Gobbi, N. Haddjeri, L. Santarelli, G. Mathew, R. Hen

CCNP News and Views

The 27th Annual Meeting of the Canadian College of Neuropsychopharmacology Kingston, Ontario, Canada, May 29-June 1, 2004

Psychopharmacology for the Clinician

What is the role of pharmacotherapy in tobacco cessation in patients with schizophrenia?
C. Els

July 2004

 J Psychiatry Neurosci 2004;29(4)

Editorial

How many good antidepressant medications have we missed?
P. Blier

CRSN Symposium: Focus on Depression, Part II

The therapeutic role of 5-HT1A and 5-HT2A receptors in depression
P. Celada, M.V. Puig, M. Amargós-Bosch, A. Adell, F. Artigas

Transcranial magnetic stimulation (TMS) of the human frontal cortex: implications for repetitive TMS treatment of depression
T. Paus, J. Barrett

CRSN Symposium: Focus on Schizophrenia

Using animal models to test a neurodevelopmental hypothesis of schizophrenia
B.K. Lipska

Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes
W.R. Perlman, C.S. Weickert, M. Akil, J.E. Kleinman

Glutamate co-transmission as an emerging concept in monoamine neuron function
L.É. Trudeau

CCNP News and Views

Canadian College of Neuropsychopharmacology 2004 Award Winners

September 2004

J Psychiatry Neurosci 2004;29(5)

Editorial

Ethical conduct of journal editors
S.N. Young, R.T. Joffe

Commentary

Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders
M.D. Berry

Review Papers

Implication des gènes du système sérotoninergique dans la vulnérabilité aux conduites suicidaires
P. Courtet, F. Jollant, D. Castelnau, B. Astruc, C. Buresi, A. Malafosse

Mother to infant or infant to mother? Reciprocal regulation of responsiveness to stress in rodents and the implications for humans
C.D. Walker, S. Deschamps, K. Proulx, M. Tu, C. Salzman, B. Woodside, S. Lupien, N. Gallo-Payet, D. Richard

Research Paper

Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors
M. Gitlin, L.L. Altshuler, M.A. Frye, R. Suri, E.L. Huynh, L. Fairbanks, M. Bauer, S. Korenman

CCNP News and Views

American Psychiatric Association honours founding member of the Canadian College of Neuropsychopharmacology

Psychopharmacology for the Clinician

With all the recent concern about SSRIs and suicidality, what advice should be given to the practising clinician regarding the management of a depressed young person?
Y.D. Lapierre

November 2004

J Psychiatry Neurosci 2004;29(6)

Editorial

Nitric oxide: A key player in the relation between cardiovascular disease and major depressive disorder?
J.M. Le Mellédo, N. Mahil, G.B. Baker

Review Papers

The role of the hippocampus in the pathophysiology of major depression
S. Campbell, G. MacQueen

Interactions between ß-amyloid and central cholinergic neurons: implications for Alzheimer’s disease
S. Kar, S.P.M. Slowikowski, D. Westaway, H.T.J. Mount

Research Paper

Testing the association between thyroid dysfunction and psychiatric diagnostic group in an iodine-deficient area
D. Hermann, W. Hewer, F. Lederbogen

Potential benefits of quetiapine in the treatment of substance dependence disorders
S.P Sattar, S.C. Bhatia, F. Petty

Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission
G. Tringali, J.M. Aubry, K. Moscianese, C. Zamori, M. Vairano, P. Preziosi, P. Navarra, G. Pozzoli

Brief Report

Tardive dyskinesia in 2 patients treated with ziprasidone
J. Ananth, K.S. Burgoyne, D. Niz, M. Smith

CCNP News and Views

The 27th Annual Meeting of the Canadian College of Neuropsychopharmacology, Kingston, Ontario, Canada, May 29 to June 1, 2004
C. Flores, T. Paine, L.K. Srivastava, M. Leyton

Psychopharmacology for the Clinician

Although antidepressants and anxiolytics are frequently used together to treat depression in the acute phase, how effective is the concomitant use of these drugs?
S. Kanba

January 2005

J Psychiatry Neurosci 2005;30(1)

Editorial

Depression and multiple sclerosis: a potential way to understand the biology of major depressive illness
R.T. Joffe

Research Papers

The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses
J. Shen, S.H. Kennedy, R.D. Levitan, L. Kayumov, C.M. Shapiro

Increased occipital delta dipole density in major depressive disorder determined by magnetoencephalography
A. Fernández, A. Rodriguez-Palancas, M. López-Ibor, P. Zuluaga, A. Turrero, F. Maestú, C. Amo, J.J. López-Ibor Jr., T Ortiz

Is initiation of smoking associated with the prodromal phase of schizophrenia?
K. Riala, H. Hakko, M. Isohanni, A. Pouta, P. Räsänen

Adult metachromatic leukodystrophy: disorganized schizophrenia-like symptoms and postpartum depression in 2 sisters
H. Gregoric Kumperscak, E. Paschke, P. Gradisnik, J. Vidmar, S. Umek Bradac

Information-processing deficits and cognitive dysfunction in panic disorder
S. Ludewig, M.A. Geyer, M. Ramseier, F.X. Vollenweider, E. Rechsteiner, K. Cattapan-Ludewig

The effect of methionine and S-adenosylmethionine on S-adenosylmethionine levels in the rat brain
S.N. Young, M. Shalchi

Brief Report

Preliminary evidence for an association between aggression and hostile behaviour and 3α,5α-tetrahydroprogesterone plasma levels in schizophrenia
G. Spalletta, E. Romeo, G. Bonaviri, G. Bernardi, C. Caltagirone, F. di Michele

Object versus spatial visual mental imagery in patients with schizophrenia
A. Aleman, E.H.F. de Haan, R.S. Kahn

Letter to the Editors

Quetiapine-induced hypothyroidism
S. Ramaswamy, Z. Siddiqui, S. Saharan, T.L. Gabel, S.C. Bhatia Reviewers

Reviewers

Reviewers

Psychopharmacology for the Clinician

What is the optimal implementation of bright light therapy for seasonal affective disorder (SAD)?
Robert D. Levitan

March 2005

J Psychiatry Neurosci 2005;30(2)

Editorial

Repetitive transcranial magnetic stimulation for the treatment of depression: To stimulate or not to stimulate?
Z.J. Daskalakis

Review Papers

Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis
J.L. Couturier

A framework for targeting alternative brain regions with repetitive transcranial magnetic stimulation in the treatment of depression
D.J.L.G. Schutter, J. van Honk

Research Papers

Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study
B. Gagnon, G. Low, G. Schreier

Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene
M. Le Saux, T. Di Paolo

Perinatal complications in children with attention-deficit hyperactivity disorder and their unaffected siblings
L. Ben Amor, N. Grizenko, G. Schwartz, P. Lageix, C. Baron, M. Ter-Stepanian, M. Zappitelli, V. Mbekou, R. Joober

Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study
D. Centonze, M.G. Palmieri, L. Boffa, M. Pierantozzi, P. Stanzione, L. Brusa, M.G. Marciani, A. Siracusano, G. Bernardi, M.D. Caramia

Brief Report

Autistic-like findings associated with a urea cycle disorder in a 4-year-old girl
I. Görker, Ü. Tüzün

CCNP News and Views

The 28th Annual Meeting of the Canadian College of Neuropsychopharmacolgy

Psychopharmacology for the Clinician

Selective serotonin reuptake inhibitors (SSRIs) and depression after myocardial infarction (MI)
J.M. Le Mellédo, J. Perez-Parada

May 2005

J Psychiatry Neurosci 2005;30(3)

Editorial

Universities, governments and industry: Can the essential nature of universities survive the drive to commercialize?
S.N. Young

CCNP News and Views

2005 Award Winners; 28th Annual Meeting

Review Papers

Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder
P. Zwanzger, R. Rupprecht

Is the cerebellum relevant in the circuitry of neuropsychiatric disorders?
J. Z. Konarski, R.S. McIntyre, L.A. Grupp, S.H. Kennedy

Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: Is there evidence for a schizo-obsessive subtype of schizophrenia?
A. Bottas, R.G. Cooke, M.A. Richter

Research Papers

Amitriptyline and fluoxetine protect PC12 cells from cell death induced by hydrogen peroxide
N. Kolla, Z. Wei, J.S. Richardson, X.M. Li

Loudness dependence of the auditory evoked potential and response to antidepressants in Chinese patients with major depression
T.W. Lee, Y.W.Y. Yu, T.J. Chen, S.J. Tsai

Psychopharmacology for the Clinician

What are the treatment options for comorbid alcohol abuse and depressive disorders?
M. Dongier